sb 203580 has been researched along with Chronic Kidney Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Che, X; Mou, S; Ni, Z; Shao, X; Tian, L; Wang, Q; Xie, Y; Xu, W; Xu, Y; Zhang, M | 1 |
1 other study(ies) available for sb 203580 and Chronic Kidney Diseases
| Article | Year |
|---|---|
Kidney Injury Molecule-1 is Elevated in Nephropathy and Mediates Macrophage Activation via the Mapk Signalling Pathway.
Topics: Acute Kidney Injury; Adult; Aged; Animals; Case-Control Studies; Cell Line; Disease Models, Animal; Female; Glomerular Filtration Rate; Hepatitis A Virus Cellular Receptor 1; Humans; Imidazoles; Interleukin-6; Macrophage Activation; Macrophages; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Middle Aged; Mitogen-Activated Protein Kinases; Pyridines; RAW 264.7 Cells; Recombinant Proteins; Renal Insufficiency, Chronic; Tumor Necrosis Factor-alpha | 2017 |